Versant Vantage I, L.P.
Related Filers (23)
- Versant Venture Capital VI, L.P. (39)
- Versant Vantage I GP, L.P. (28)
- Versant Vantage I GP-GP, LLC (28)
- Black Diamond Therapeutics, Inc. (22)
- Versant Voyageurs I Parallel, L.P. (22)
- Versant Voyageurs I, L.P. (22)
- Versant Ventures VI GP, L.P. (15)
- Versant Ventures VI GP-GP, LLC (15)
- Repare Therapeutics Inc. (10)
- Oyster Point Pharma, Inc. (9)
- Versant Venture Capital IV, L.P. (9)
- Versant Ventures IV, LLC (9)
- Versant Side Fund IV, L.P. (9)
- Woiwode Thomas (2)
- Passage BIO, Inc. (2)
- Aprea Therapeutics, Inc. (2)
- Pandion Therapeutics, Inc. (2)
- Aligos Therapeutics, Inc. (2)
- Monte Rosa Therapeutics, Inc. (2)
- Versant Ventures VII GP, L.P. (1)
- RayzeBio, Inc. (1)
- Versant Venture Capital VII, L.P. (1)
- Versant Ventures VII GP-GP, LLC (1)
- Show More ...
Ownership (52)
3
Thursday, 9/14/2023
RayzeBio, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 1/4/2023
Oyster Point Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/7/2022
Repare Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/7/2022
Oyster Point Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/23/2021
Oyster Point Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/20/2021
Oyster Point Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 8/9/2021
Repare Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/30/2021
Monte Rosa Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 6/23/2021
Monte Rosa Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 6/3/2021
Repare Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/14/2021
Oyster Point Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/7/2021
Repare Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/30/2021
Oyster Point Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 2/19/2021
Oyster Point Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/18/2021
Repare Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/2/2021
Repare Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/19/2021
Repare Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/17/2020
Repare Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/16/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/1/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/25/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 11/23/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 11/19/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/17/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 11/13/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 11/12/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/10/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 11/6/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/28/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/20/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/20/2020
Aligos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 10/15/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 10/15/2020
Aligos Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 10/13/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 10/8/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 9/21/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 8/20/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 8/14/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/12/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/29/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/21/2020
Pandion Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 7/16/2020
Pandion Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 6/25/2020
Repare Therapeutics Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 6/18/2020
Repare Therapeutics Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 5/20/2020
Aprea Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/3/2020
Passage BIO, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 2/27/2020
Passage BIO, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 2/5/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 1/29/2020
Black Diamond Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 11/4/2019
Oyster Point Pharma, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 10/30/2019
Oyster Point Pharma, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 10/7/2019
Aprea Therapeutics, Inc.: Statement of changes in beneficial ownership of securities